NCT00049712View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

etaracizumab

Trial Locations (1)

53792

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00049712 - Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter